ART extends distribution agreement with GE Healthcare

11 January 2007

Montreal, Canada. ART Advanced Research Technologies Inc. (TSX: ARA), has announced the extension of its current agreement with GE Healthcare for the exclusive worldwide distribution of its eXplore Optix preclinical optical molecular imaging system.

The extension of the current distribution agreement will allow ART and GEHC to maintain the ongoing sales, marketing and customer support operations for eXplore Optix while the parties workout a new multi-year agreement. Discussions have been ongoing between ART and GEHC over the last few months with respect to the conclusion of a new distribution agreement that will aim to establish the conditions for the effective commercialization of ART’s eXplore Optix product.

The previous agreement, signed in November 2003, gave GE rights to be the exclusive worldwide distributor of the eXplore Optix preclinical molecular imaging system. ART retained all manufacturing and sourcing responsibilities, while GE became responsible for sales, distribution, marketing, and customer service worldwide.

To top

To top